Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma | NEJM
Incorporating brentuximab vedotin into the treatment of advanced-stage classic Hodgkin’s lymphoma improves outcomes in adult and pediatric patients. However, brentuximab vedotin increases the toxic…